BR112015013725A2 - cepa de levedura - Google Patents

cepa de levedura

Info

Publication number
BR112015013725A2
BR112015013725A2 BR112015013725A BR112015013725A BR112015013725A2 BR 112015013725 A2 BR112015013725 A2 BR 112015013725A2 BR 112015013725 A BR112015013725 A BR 112015013725A BR 112015013725 A BR112015013725 A BR 112015013725A BR 112015013725 A2 BR112015013725 A2 BR 112015013725A2
Authority
BR
Brazil
Prior art keywords
thermotolerance
alleles
genes
yeast
yeast strain
Prior art date
Application number
BR112015013725A
Other languages
English (en)
Inventor
Thevelein Johan
Foulquié-Moreno Maria
Yang Yudi
Original Assignee
Katholieke Univ Leuven K U Leuven R&D
Vib Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Univ Leuven K U Leuven R&D, Vib Vzw filed Critical Katholieke Univ Leuven K U Leuven R&D
Publication of BR112015013725A2 publication Critical patent/BR112015013725A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

resumo patente de invenção: "identificação de genes de termotolerância em levedura". a presente invenção refere-se a um método para identificar genes que sejam determinadores importantes de termotolerância em levedura. a invenção se refere, adicionalmente, a genes, identificados com o dito método, especialmente alelos específicos de prp42 e o uso de tais alelos para aumentar a termotolerância. a mesma está relacionada, adicionalmente, a linhagens recombinantes transformadas com tais alelos.
BR112015013725A 2012-12-12 2013-12-12 cepa de levedura BR112015013725A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12196785 2012-12-12
PCT/EP2013/076344 WO2014090930A1 (en) 2012-12-12 2013-12-12 Identification of thermotolerance genes in yeast

Publications (1)

Publication Number Publication Date
BR112015013725A2 true BR112015013725A2 (pt) 2017-11-14

Family

ID=47355881

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015013725A BR112015013725A2 (pt) 2012-12-12 2013-12-12 cepa de levedura

Country Status (6)

Country Link
US (1) US20150307833A1 (pt)
EP (1) EP2931873A1 (pt)
AU (1) AU2013357309A1 (pt)
BR (1) BR112015013725A2 (pt)
CA (1) CA2894747A1 (pt)
WO (1) WO2014090930A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2900690B1 (en) 2012-09-25 2019-07-17 Vib Vzw Mutant yeast strain with decreased glycerol production
AU2014255759B2 (en) 2013-04-15 2019-10-03 Katholieke Universiteit Leuven, K.U.Leuven R&D Yeast alleles involved in maximal alcohol accumulation capacity and tolerance to high alcohol levels
WO2018115251A1 (en) 2016-12-21 2018-06-28 Vib Vzw Xylose isomerases that confer efficient xylose fermentation capability to yeast

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1338608A3 (en) * 2001-12-20 2004-05-06 Cellzome Ag Protein complexes and methods for their use
US20100311137A1 (en) * 2009-06-08 2010-12-09 Ut-Battelle, Llc Microorganisms Having Enhanced Tolerance To Inhibitors and Stress

Also Published As

Publication number Publication date
CA2894747A1 (en) 2014-06-19
US20150307833A1 (en) 2015-10-29
EP2931873A1 (en) 2015-10-21
AU2013357309A1 (en) 2015-07-09
WO2014090930A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
BR112014000466A2 (pt) polipeptídeos quiméricos e híbridos fator viii, métodos de uso dos mesmos
UY33625A (es) Uso de ingredientes activos para controlar nematodos en cultivos resistentes a nematodos
EP4324845A3 (en) Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
GT201200293A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
BR112013004012A2 (pt) anticorpos para o receptor de fator de crescimento epidérmico 3 (her3).
CR20120406A (es) Identificación de mutación lkb1 como un biomarcador predictivo para sensibilidad a inhibidores de tor cinasa
BR112014001834A2 (pt) biocontrole de nematoides
BR112016003671A2 (pt) gene de resistência a ferrugem
IN2015MN00436A (pt)
ES2627330T3 (es) Uso de JAZ5a para mejorar la resistencia a la sequía en una planta
BR112015001892A8 (pt) Cocleados feitos com fosfatidilserina de soja e método para a produção de cocleados de fosfatidilserina de soja/ativo biológico
GT201600066A (es) Composiciones y métodos para inhibir la expresión del gen alas1
EA201300876A1 (ru) Мутантная целлобиогидролаза
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
BR112012023836A2 (pt) composto tricíclicos e inibidores de pbk contendo os mesmos
BR112015007843A2 (pt) método para a preparação de um polímero, polímero, artigo e método de preparação de um artigo
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
AR092468A1 (es) Concentrado liquido de transferencia de calor
BR112015009287A2 (pt) biocontrole de nematódeos
BR112015024860A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose
ECSP14027694A (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
EA201300733A1 (ru) Рекомбинантные микобактерии в качестве вакцины
EA201390616A1 (ru) ЛЕЧЕНИЕ НАРУШЕНИЙ, АССОЦИИРОВАННЫХ С ГЕНОМ MeCP2
BR112015002433A2 (pt) método

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]